These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2819281

  • 1. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission.
    Torres A, Martínez F, Gómez P, Fornés G, Rojas R, Herrera C, Gómez JL, Manzanares R, García JM, Andres P.
    Bone Marrow Transplant; 1989 Nov; 4(6):609-12. PubMed ID: 2819281
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 3. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.
    Hoogerbrugge PM, Gerritsen EJ, vd Does-van den Berg A, vd Berg H, Zwinderman AH, Hermans J, Vossen JM.
    Bone Marrow Transplant; 1995 Feb; 15(2):255-9. PubMed ID: 7773215
    [Abstract] [Full Text] [Related]

  • 4. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA.
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
    Gaynon PS, Harris RE, Altman AJ, Bostrom BC, Breneman JC, Hawks R, Steele D, Zipf T, Stram DO, Villaluna D, Trigg ME.
    J Clin Oncol; 2006 Jul 01; 24(19):3150-6. PubMed ID: 16717292
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 7. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb 01; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission.
    Bacigalupo A, Van Lint MT, Frassoni F, Occhini D, Pittaluga PA, Comelli A, Dini G, Massimo L, Marmont AM.
    Bone Marrow Transplant; 1986 May 01; 1(1):75-80. PubMed ID: 3332122
    [Abstract] [Full Text] [Related]

  • 9. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL.
    Bone Marrow Transplant; 1996 May 01; 17(5):763-8. PubMed ID: 8733695
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul 01; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

  • 11. Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias.
    Suttorp M, Schmitz N, Leuschner S, Appelt M, Rister M, Schaub J.
    Bone Marrow Transplant; 1989 Dec 01; 4 Suppl 4():144-8. PubMed ID: 2697428
    [Abstract] [Full Text] [Related]

  • 12. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, Peters C, Gadner H, Henze G.
    Bone Marrow Transplant; 1995 Apr 01; 15(4):515-21. PubMed ID: 7655375
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
    Blaise D, Gaspard MH, Stoppa AM, Michel G, Gastaut JA, Lepeu G, Tubiana N, Blanc AP, Rossi JF, Novakovitch G.
    Bone Marrow Transplant; 1990 Jan 01; 5(1):7-12. PubMed ID: 2404531
    [Abstract] [Full Text] [Related]

  • 14. [Treatment results of bone marrow transplantation in Kyushu Cancer Center. Bone Marrow Transplantation Team].
    Tasaka H, Ikuno Y, Okamura J.
    Rinsho Ketsueki; 1990 Mar 01; 31(3):315-9. PubMed ID: 2366334
    [Abstract] [Full Text] [Related]

  • 15. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov 01; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
    Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA.
    N Engl J Med; 1994 Nov 10; 331(19):1253-8. PubMed ID: 7935682
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G.
    Bone Marrow Transplant; 1996 Feb 10; 17(2):191-6. PubMed ID: 8640165
    [Abstract] [Full Text] [Related]

  • 18. [Allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia].
    Maldonado MS, Otheo de Tejada E, Muñoz Villa A, García Laraña J.
    Sangre (Barc); 1993 Feb 10; 38(1):13-6. PubMed ID: 8470031
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Sharathkumar A, Saunders EF, Dror Y, Grant R, Greenberg M, Weitzman S, Chan H, Calderwood S, Freedman MH, Doyle J.
    Bone Marrow Transplant; 2004 Jan 10; 33(1):39-45. PubMed ID: 14566329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.